BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 7512798)

  • 21. Immunostaining of human melanomas by a monoclonal antibody to B700 mouse melanoma antigen.
    Xu X; Azumi N; Skelton HG; Hearing VJ; Gersten DM
    Eur J Cancer; 1996 Jan; 32A(1):168-73. PubMed ID: 8695227
    [TBL] [Abstract][Full Text] [Related]  

  • 22. S100 protein, neurone specific enolase, and nuclear DNA content in Spitz naevus.
    Rode J; Williams RA; Jarvis LR; Dhillon AP; Jamal O
    J Pathol; 1990 May; 161(1):41-5. PubMed ID: 2370597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HMB-45, S-100, NK1/C3, and MART-1 in metastatic melanoma.
    Zubovits J; Buzney E; Yu L; Duncan LM
    Hum Pathol; 2004 Feb; 35(2):217-23. PubMed ID: 14991540
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Desmoplastic malignant melanoma: a clinicopathologic analysis of 113 cases.
    de Almeida LS; Requena L; Rütten A; Kutzner H; Garbe C; Pestana D; Gomes MM
    Am J Dermatopathol; 2008 Jun; 30(3):207-15. PubMed ID: 18496419
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acral lentiginous melanoma: an immunohistochemical study of 20 cases.
    Kim YC; Lee MG; Choe SW; Lee MC; Chung HG; Cho SH
    Int J Dermatol; 2003 Feb; 42(2):123-9. PubMed ID: 12709000
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of immunohistochemical staining of the novel antibody melan-A with S100 protein and HMB-45 in malignant melanoma and melanoma variants.
    Blessing K; Sanders DS; Grant JJ
    Histopathology; 1998 Feb; 32(2):139-46. PubMed ID: 9543670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microphthalmia transcription factor and melanoma cell adhesion molecule expression distinguish desmoplastic/spindle cell melanoma from morphologic mimics.
    Koch MB; Shih IM; Weiss SW; Folpe AL
    Am J Surg Pathol; 2001 Jan; 25(1):58-64. PubMed ID: 11145252
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patterns of staining for neurone specific enolase in benign and malignant melanocytic lesions of the skin.
    Dhillon AP; Rode J
    Diagn Histopathol; 1982; 5(3):169-74. PubMed ID: 6183082
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Melanocytic lesions associated with dermatofibromas: a spectrum of lesions ranging from junctional nevus to malignant melanoma in situ.
    King R; Googe PB; Page RN; Mihm MC
    Mod Pathol; 2005 Aug; 18(8):1043-7. PubMed ID: 15803191
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Parotid involvement by desmoplastic melanoma.
    Jennings TA; Okby NT; Schroer KR; Wolf BC; Mihm MC
    Histopathology; 1996 Aug; 29(2):165-70. PubMed ID: 8872151
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aberrant intermediate filament and synaptophysin expression is a frequent event in malignant melanoma: an immunohistochemical study of 73 cases.
    Romano RC; Carter JM; Folpe AL
    Mod Pathol; 2015 Aug; 28(8):1033-42. PubMed ID: 26022451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunohistochemical evaluation of uveal melanocytic tumors. Expression of HMB-45, S-100 protein, and neuron-specific enolase.
    Burnier MN; McLean IW; Gamel JW
    Cancer; 1991 Aug; 68(4):809-14. PubMed ID: 1855181
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistochemical characterization of experimental Greene melanoma.
    Wollensak G
    Ophthalmic Res; 1992; 24(1):55-8. PubMed ID: 1608593
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Measuring S100 protein and neurone specific enolase in melanocytic tumours using video image analysis.
    Williams RA; Rode J; Dhillon AP; Jarvis LR; Skinner JM; Jamal O
    J Clin Pathol; 1986 Oct; 39(10):1096-8. PubMed ID: 2431005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Desmoplastic malignant melanoma of the oral mucosa. An underrecognized diagnostic pitfall.
    Kilpatrick SE; White WL; Browne JD
    Cancer; 1996 Aug; 78(3):383-9. PubMed ID: 8697380
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemical study of S-100 protein and neuron specific enolase (NSE) in melanocytes and the related tumors.
    Hachisuka H; Sakamoto F; Nomura H; Mori O; Sasai Y
    Acta Histochem; 1986; 80(2):215-23. PubMed ID: 3101377
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recognition of malignant melanoma by monoclonal antibody HMB-45. An immunohistochemical study of 200 paraffin-embedded cutaneous tumors.
    Wick MR; Swanson PE; Rocamora A
    J Cutan Pathol; 1988 Aug; 15(4):201-7. PubMed ID: 3053811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An immunocytochemical study of malignant melanoma and its differential diagnosis from other malignant tumours.
    Gatter KC; Ralfkiaer E; Skinner J; Brown D; Heryet A; Pulford KA; Hou-Jensen K; Mason DY
    J Clin Pathol; 1985 Dec; 38(12):1353-7. PubMed ID: 3908491
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HMB45 negative spindle cell malignant melanoma.
    Skelton HG; Maceira J; Smith KJ; McCarthy WF; Lupton GP; Graham JH
    Am J Dermatopathol; 1997 Dec; 19(6):580-4. PubMed ID: 9415614
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NGFR-positive desmoplastic melanomas with focal or absent S-100 staining: Further evidence supporting the use of both NGFR and S-100 as a primary immunohistochemical panel for the diagnosis of desmoplastic melanomas.
    Radfar A; Stefanato CM; Ghosn S; Bhawan J
    Am J Dermatopathol; 2006 Apr; 28(2):162-7. PubMed ID: 16625082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.